NCT06564571Recruiting
Artificial Intelligence in Endoscopic Ultrasound
Source: ClinicalTrials.gov · Last updated 31 May 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
The objective of the study is to determine if this artificial intelligence system is capable of detecting abnormalities in the pancreas that are identified by an endoscopist at endoscopic ultrasound procedures.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 310 (estimated)
- First submitted
- 19 Aug 2024
- Start date
- 19 Jan 2024
- Primary completion date
- 31 Dec 2026
- Lead sponsor
- Orlando Health, Inc.
- Diseases
- Pancreatic cancer
- NCT number
- NCT06564571
What you commit to
- Study type: Observational
- Planned participants: 310
- From 19 Jan 2024 to the primary completion date, 31 Dec 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Age
- Age \< 18 years
Who the study is looking for
- Age ≥ 18 years
- Any patient undergoing endoscopic ultrasound examination
Age in the registry: 18 years to 100 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Orlando Health Coordinator of this site? Confirm its status | Orlando | United States | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.